GeneDx Holdings Corp.
WGS · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $2,067 | $67 | $89 | $482 |
| - Cash | $85 | $100 | $137 | $401 |
| + Debt | $116 | $120 | $77 | $33 |
| Enterprise Value | $2,098 | $87 | $29 | $114 |
| Revenue | $305 | $203 | $235 | $212 |
| % Growth | 50.8% | -13.7% | 10.6% | – |
| Gross Profit | $194 | $90 | -$27 | -$17 |
| % Margin | 63.6% | 44.4% | -11.4% | -7.8% |
| EBITDA | -$1 | -$136 | -$398 | -$221 |
| % Margin | -0.4% | -67.4% | -169.7% | -104% |
| Net Income | -$52 | -$176 | -$549 | -$245 |
| % Margin | -17.1% | -86.8% | -233.9% | -115.6% |
| EPS Diluted | -1.94 | -7.23 | -53.63 | -74.93 |
| % Growth | 73.2% | 86.5% | 28.4% | – |
| Operating Cash Flow | -$28 | -$180 | -$319 | -$190 |
| Capital Expenditures | -$5 | -$6 | -$14 | -$21 |
| Free Cash Flow | -$34 | -$186 | -$333 | -$211 |